Cosmetics Testing and Multi-Market Regulatory Compliance Support

Testing based on cosmetic formulation, product type and destination market, including microbiological, physicochemical, restricted-substance, stability and packaging-compatibility work, with support for EU safety documentation and U.S. MoCRA preparation.

Service overview

Cosmetic compliance combines product definition, formulation safety, manufacturing controls, label claims and market-specific registration or notification duties. Tests are selected according to dosage form, area of use, user population, composition and destination market. SCS Testing provides risk-based testing and document support while treating EU CPNP/CPSR, U.S. MoCRA and other jurisdictional processes separately; registration or notification is not presented as official product certification.

Applicable products or businesses

• Skin care, cleansing, hair care, colour cosmetics, fragrance, oral care and other products meeting the cosmetic definition
• Cosmetic manufacturers, brand owners, responsible persons, importers and cross-border sellers
• Projects requiring formulation-risk, label-claim or market-document gap assessment

Target market

• China, the EU, the United States and other specifically identified cosmetic markets

Regulatory authority

• Cosmetics authorities in the destination market
• EU Member State authorities and the European Commission
• U.S. FDA for MoCRA-related duties

Regulations, directives and standards

• Destination-market cosmetic safety, labelling and manufacturing requirements
• EU Regulation (EC) No 1223/2009 and CPSR/CPNP processes
• U.S. FD&C Act and MoCRA facility registration, product listing and safety-substantiation duties

Service scope

• Formulation and ingredient regulatory screening
• Microbiological, physicochemical, metals, prohibited/restricted substance and preservative-system testing
• Stability, packaging compatibility and use-safety support
• Gap review for labels, claims, PIF/CPSR or MoCRA information

Service process

• Confirm product definition, dosage form, use and destination market
• Review the complete formulation, raw-material evidence and claims
• Build the safety and regulatory test plan
• Complete testing and address formulation, microbiological or packaging risks
• Compile market documents for the responsible party to complete registration, listing or notification

Information required

• Complete INCI formulation, concentrations and raw-material specifications/SDSs
• Manufacturing process, quality specifications and microbiological controls
• Packaging materials, claims, labels and use instructions
• Historical stability, preservative-challenge or safety data
• Manufacturer, EU responsible person or U.S. responsible person details

Sample requirements

• Samples must come from identified batches and represent the final formulation and packaging
• Stability and packaging-compatibility work requires sufficient retained and control samples
• Products with multiple fragrances or colours are selected according to formulation differences

## Reports, certificates or registration outcomes Outputs may include agreed test reports, formulation regulatory screening and document-gap records. CPNP notification, CPSR, MoCRA registration/listing and other market procedures are completed by the appropriately responsible parties; a test report is not market approval.

Factors affecting timing

Microbiological, stability, preservative-challenge and packaging-compatibility work can require different observation periods. Formulation completeness, corrective work and market-document requirements also affect timing.

Common compliance risks

• Incomplete formulations or unidentified ingredients distort the regulatory assessment
• A test report is treated as proof that CPNP, CPSR or MoCRA duties are complete
• Claims exceed cosmetic use or lack supporting evidence
• Formulation, raw-material supplier or packaging changes are not reassessed

Is there a fixed cosmetic test package?

No. The plan depends on dosage form, area of use, user population, formulation, claims and destination market.

## Does successful testing complete EU CPNP notification?

No. CPNP also involves the responsible person, PIF, CPSR, labels and notification data; testing is only part of the evidence.

Does MoCRA listing mean FDA approval?

No. FDA states that cosmetic facility registration and product listing are not an approval program.

Related services

• FDA cosmetics MoCRA compliance
• EU CPNP/CPSR document support
• Cosmetic packaging-compatibility testing
• Cosmetic label and claim review

Information for an initial assessment

Provide the product name, model, intended use, target market, bill of materials and available reports so that the applicable route and evidence gaps can be assessed.